"While waiting for the FDA to be done with the review and we have negotiated the label with FDA, we are continuing to build out and hire people for our Danbury, Connecticut facility."
If your product wasn't getting approved, why would you need to negotiate the label? Why would you keep building out your manufacturing facility?
Think about it folks...............I believe we get the early nod from FDA! Sit tight and hang on to your shares, because this is going to be one helluva ride North!!!!!! My earlier prediction was $25-$30 on approval, but since none of the shorts seem to be covering and institutions are adding more. I think we could easily see $50 on approval. Partnership sends shares much higher.
FDA will approve, not a moment prior to 7.15. Label restrictions will mildly disappoint and there will be a double price jumpjump as a result of the approval on 7.15 & the announcement of 2 partners, likely including Sanofi to expedite European approval & a domestic BP prior to 8.15.
Like the musing, but think the post partner number is still $22/3. Be very pleased to be wrong on the upside.
Exaggerated false hope on price is the enemy of patience & satisfaction. Let the market come to MNKD & a broad smile shall follow, Grasshopper.